Bodhi Tree Biotechnology Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024
Revenue	0.01	0.02	0.04
Revenue Growth (YoY)	-71.43%	-59.52%	-
Gross Profit	0.01	0.02	0.04
Selling, General & Admin	0.15	0.16	0.12
Operating Expenses	0.15	0.16	0.12
Operating Income	-0.14	-0.15	-0.07
Interest & Investment Income	0	0	-
Pretax Income	-0.14	-0.15	-0.07
Income Tax Expense	0	0	-
Net Income	-0.14	-0.15	-0.07
Net Income to Common	-0.14	-0.15	-0.07
Shares Outstanding (Basic)	25	25	13
Shares Outstanding (Diluted)	25	25	13
Shares Change (YoY)	99.01%	99.01%	-
EPS (Basic)	-0.01	-0.01	-
EPS (Diluted)	-0.01	-0.01	-
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-1131.58%	-868.34%	-177.01%
Profit Margin	-1148.64%	-880.39%	-177.01%
EBIT	-0.14	-0.15	-0.07
EBIT Margin	-	-	-177.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.